jcm-logo

Journal Browser

Journal Browser

Advances in Minimally Invasive Gynecologic Surgery: Optimizing Outcomes and Perioperative Strategies

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Obstetrics & Gynecology".

Deadline for manuscript submissions: 20 March 2026 | Viewed by 1431

Special Issue Editor


E-Mail Website
Guest Editor
Division of Minimally Invasive Gynecologic Surgery, Department of Obstetrics and Gynecology, Cedars Sinai Medical Center, Los Angeles, CA, USA
Interests: minimally invasive gynecologic surgery; myomectomy; hysterectomy; endometriosis excision; hysteroscopy; laparoscopic surgery

Special Issue Information

Dear Colleagues,

Minimally Invasive Gynecologic Surgery (MIGS) has become the standard of care for many gynecologic conditions, including fibroids, endometriosis, benign adnexal masses, and early-stage endometrial cancer. Studies increasingly demonstrate that MIGS is associated with shorter hospital stays, lower complication rates, and quicker recovery, particularly among well-selected patient populations.

This Special Issue aims to highlight the evolving landscape of MIGS, with a focus on improving patient outcomes, refining surgical techniques, and identifying predictors of perioperative risk. From preoperative assessments to perioperative strategies. this issue seeks to provide a comprehensive overview of both the clinical efficacy and systemic integration of MIGS.

We welcome submissions of original research articles, reviews, and clinical insights from researchers, clinicians, and industry experts. Topics of interest include, but are not limited to:

  • Risk prediction and patient stratification
  • Surgical innovations and robotic approaches
  • Preoperative and postoperative management strategies

We look forward to your contributions to this Special Issue, which aims to inform, inspire, and advance the future of minimally invasive gynecologic surgery.

Dr. Raanan Meyer
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • minimally invasive gynecologic surgery
  • MIGS
  • laparoscopy
  • robotic surgery
  • endometrial cancer
  • endometriosis

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

9 pages, 204 KB  
Article
Predictors for Using Electricity During Hysteroscopic Removal of Retained Products of Conception
by Liat Mor, Tzvi Leibowitz, Emilie Ben-Ezry, Ram Kerner, Ran Keidar, Eran Weiner, Ron Sagiv and Ohad Gluck
J. Clin. Med. 2025, 14(21), 7587; https://doi.org/10.3390/jcm14217587 - 26 Oct 2025
Viewed by 384
Abstract
Background: Retained products of conception (RPOC) can be managed via hysteroscopic removal using mechanical or electrosurgical techniques. Electrosurgery introduces greater technical complexity and may reflect more adherent or vascular tissue, yet preoperative predictors for its necessity remain poorly defined. Objective: The objective of [...] Read more.
Background: Retained products of conception (RPOC) can be managed via hysteroscopic removal using mechanical or electrosurgical techniques. Electrosurgery introduces greater technical complexity and may reflect more adherent or vascular tissue, yet preoperative predictors for its necessity remain poorly defined. Objective: The objective of this study was to evaluate clinical outcomes and identify preoperative predictors associated with the use of electrosurgery during hysteroscopic removal of RPOC. Methods: In this retrospective cohort study conducted at a single tertiary center, we reviewed 551 cases of hysteroscopic RPOC removal performed between January 2008 and December 2022. Patients were categorized based on intraoperative use of electrosurgical instruments. Clinical, sonographic, and operative data were compared between groups. Multivariate logistic regression was used to identify independent predictors of electrosurgical use. Results: Electrosurgical intervention was required in 84 patients (15.2%). Compared with those treated without electricity, these patients were older (33.2 ± 6.4 vs. 31.2 ± 5.8 years, p = 0.004), more likely to be smokers (15.4% vs. 8.1%, p = 0.033), and had higher rates of prior hysteroscopy (5.9% vs. 1.0%, p = 0.002). Electrosurgical use was more common following vaginal delivery than abortion (57.1% vs. 24.8%, p < 0.001), particularly when manual placental removal was performed (23.8% vs. 5.7%, p < 0.001). Larger RPOC size and positive Doppler flow were also associated with the use of electrosurgery. On multivariate analysis, maternal age, postpartum RPOC, manual placental removal, and Doppler vascularity remained independent predictors. No significant differences were observed in short-term postoperative complications. Conclusions: Older age, postpartum RPOC, manualysis, and vascularity on ultrasound are preoperative predictors for the need of electrosurgical intervention during hysteroscopic removal of RPOC. Identifying these factors may improve surgical planning and patient counseling. Future prospective studies incorporating advanced hysteroscopic technologies are warranted. Full article

Review

Jump to: Research

16 pages, 1575 KB  
Review
Minimizing Hemorrhage Risk Strategies in Cervical Pregnancy—Stepwise Pharmacologic Priming and Delayed Surgical Evacuation: A Narrative Review
by Victor Bogdan Buciu, Gabriel Florin Răzvan Mogoș, Nicolae Albulescu, Sebastian Ciurescu, Dorin Novacescu, Mihai Ionac, Abhinav Sharma, Nilima Rajpal Kundnani and Denis Serban
J. Clin. Med. 2025, 14(21), 7489; https://doi.org/10.3390/jcm14217489 - 22 Oct 2025
Viewed by 840
Abstract
Background: CP (CP) and HCP (HCP) are rare and high-risk conditions, often historically managed with radical intervention and associated with hemorrhage and fertility loss. Objective: To summarize current evidence on the conservative, fertility-preserving management of cervical and heterotopic cervical pregnancies and [...] Read more.
Background: CP (CP) and HCP (HCP) are rare and high-risk conditions, often historically managed with radical intervention and associated with hemorrhage and fertility loss. Objective: To summarize current evidence on the conservative, fertility-preserving management of cervical and heterotopic cervical pregnancies and to illustrate a stepwise pharmacologic protocol applied in our tertiary center. Methods: A narrative literature review (PubMed, Scopus, Web of Science; inception—July 2025) was conducted using the following key terms: “CP,” “HCP,” “methotrexate,” “mifepristone,” “misoprostol,” “uterine artery embolization,” “hysteroscopy,” and “Doppler ultrasound.” We integrated a personal institutional case that applied stepwise pharmacologic priming, Doppler-guided surveillance, and delayed evacuation. Results: Evidence—primarily from case reports and small series—supports conservative, multi-modal strategies combining systemic or local methotrexate ± mifepristone, timed to Doppler-confirmed vascular regression, before surgical intervention. Adjuncts such as misoprostol, hysteroscopic resection, balloon tamponade, and uterine artery embolization further reduce hemorrhage risk while maintaining fertility. Our case utilized a novel, incremental dosing strategy of mifepristone followed by methotrexate, a week-long interval to confirm vascular involution via Doppler, and delayed suction curettage with minimal blood loss. Conclusions: Conservative, imaging-guided management is promising for reducing hemorrhagic complications and preserving fertility in CP/HCP. Future multicenter registries and standardized Doppler-based protocols are urgently needed to refine decision-making and optimize outcomes. Full article
Show Figures

Figure 1

Back to TopTop